MedPage Today (1/26, George) reports, “Vaccination against herpes zoster (shingles) was tied to significantly less dementia risk, data from Canada’s network of primary care records showed.” Investigators found that “being eligible for a free live-attenuated zoster vaccine (Zostavax) was associated with reduced probability of a new dementia diagnosis by an absolute difference of 2.0 percentage points (95% CI 0.4-3.5, P=0.012) over 5.5 years.” The findings were published in Lancet Neurology.
Related Links:
— MedPage Today (requires login and subscription)